Anti-Human FZD10 Therapeutic Antibody (OTSA101)
Recombinant Chimeric monoclonal antibody expressed in CHO binding to Human FZD10. OTSA101 is an antibody drug targets a novel tumor-specific antigen FZD10 (Frizzled homolog 10), used for cancer therapy, has conducted phase I clinical trial for synovial sarcoma, which is a type of soft tissue sarcoma.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-295CL |
Pricing | Inquiry |
Target | FZD10 |
Species Reactivity | Human |
Type | Antibody |
Applications | RIA, IHC |
Storage |
|